Results 41 to 50 of about 2,440,020 (219)

The effect of ovarian stimulation protocol on follicular asynchrony during in vitro fertilization – A retrospective cohort study

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective To examine the effect of controlled ovarian stimulation (COS) protocol on follicular synchrony in a subsequent in vitro fertilization (IVF) cycle in patients whose previous cycle was canceled due to asynchrony. Methods A single‐center retrospective‐cohort study (January 2018–March 2024), including women undergoing IVF who had: (1) a ...
Alyssa Hochberg, Maria Hincapie, Uri Amikam, Nir Kugelman, William Buckett, Shauna Reinblatt   +5 more
wiley   +1 more source

Anti-Müllerian hormone (ovarian reserve) in rheumatoid arthritis patients: correlation with disease activity

Egyptian Rheumatology and Rehabilitation
Background Rheumatoid arthritis is considered one of the most common chronic inflammatory autoimmune diseases that lead to affection of several joints, as well as extra-articular organ involvement.
Traez Israel, Hala Abdulhady Saleh, Sahar Fathi Ahmed, Youssy Saeed Eshak Gergius   +3 more
doaj   +1 more source

The reproducibility of serum anti-Müllerian hormone in subfertile women: Within and between patient variability

, 2011
Serum anti-Müllerian hormone concentrations vary significantly over time and this should be taken into account when tailoring treatment protocols for patients undergoing controlled ovarian hyperstimulation (COH).
Pemberton, Philip W., Stephen A. Roberts, Alexander Smith, Allen P. Yates, Luciano G. Nardo, Yates, Allen P., Sree D. Patchava, Rustamov, Oybek, Philip W. Pemberton, Smith, Alexander, Nardo, Luciano G., Patchava, Sree D., Oybek Rustamov, Roberts, Stephen A.   +13 more
core   +1 more source

Anti-Müllerian hormone - A hormone with narrow spectrum of action and broad spectrum of clinical significance [PDF]

, 2014
AMH (Anti-Müllerian Hormone, Müllerian Inhibiting Substance or Factor) is a member of the transforming growth factor - " family, secreted by the fetal and prepubertal testicular Sertoli cells, and to a lesser amount by the granulosa cells of the small ...
Mladenov, Vilhelm; UMHAT `Sveta Marina`, First Pediatric Clinic
core   +1 more source

Longitudinal AMH trajectories, ovarian reserve recovery, and fertility outcomes after multiagent chemotherapy for high‐risk gestational trophoblastic neoplasia: A real‐world cohort study

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective To characterize anti‐Müllerian hormone (AMH) recovery after multiagent chemotherapy for high‐risk gestational trophoblastic neoplasia (GTN) and evaluate the impact of regimen and hysterectomy. Methods This was a retrospective cohort of 68 high‐risk GTN patients treated with EMA/CO (etoposide, methotrexate, actinomycin D ...
Wei Xue, Tianyi Chen, Yuxiao Wu, Tong Ren, Jun Zhao, Fengzhi Feng, Xirun Wan, Yang Xiang, Junjun Yang   +8 more
wiley   +1 more source

Anti-Mullerian Hormone Role in In Vitro Fertilization Outcome

Advanced Medical Journal
Background and objectives: The in vitro fertilization plays a significant role for human development in last decades. Anti-müllerian hormone level evaluation is indicator of ovarian reserve.
Chiman Khudhur Mawlood
doaj   +1 more source

Anti-Müllerian hormone: structure, properties and appliance

, 2016
Anti-Müllerian hormone (AMH) is a glycoprotein produced by the granulosa cells of preantral and small antral follicles. AMH concentrations reflect ovarian physiology with high precision, thus serving as a more sensitive marker of the ovarian reserve than
Leszcz, Agnieszka, Tkaczuk-Włach, Joanna, Kotarski, Jan, Rzeszowska, Marzena; Ab ovo Sp. z o.o., Family Health Center, Lublin, Poland, Putowski, Lechosław, Hałabiś, Magdalena, Polak, Grzegorz   +6 more
core   +1 more source

Anti-Müllerian hormone (AMH) as a good predictor of time of menopause [PDF]

, 2017
Anti-Müllerian hormone (AMH) in women is secreted by granulosa cells in late preantral and small antral follicles. AMH seems to be a very stable marker having some advantages over other biochemical and biophysical markers and is very useful in the ...
Aleksandra Kruszyńska, Jadwiga Słowińska-Srzednicka   +1 more
core   +1 more source

Fertility counseling and preservation considerations in patients with gynecologic and non‐gynecologic BRCA and Lynch‐associated malignancies

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Lynch syndrome and BRCA‐mutation associated malignancies are fortunately rare. Affected patients have an increased risk of cancer diagnosis at a young age, often significantly overlapping with their reproductive years. In helping these patients, oncologists must navigate the following areas of care: cancer prevention, impact of cancer ...
Anna Weimer, Nadeem Abu‐Rustum, David Mutch, Mauricio Cuello, Angélica Fletcher, Hextan Y. S. Ngan, Nozomu Yanaihara, Rene Pareja, Christina Fotopoulou, Kenneth Ruzindana, Ka Yu Tse, Yana Zou, Neerja Bhatla, Ting‐Chang Chang, Munanchiso Ndukwe Iheme Jr, Jalid Sehouli, Nicole Conchin, Eva Chalas, Sarikapan Wilailak, Barbara Schmalfeldt, Alexander B. Olawaiye   +20 more
wiley   +1 more source

Correlation between anti-Mullerian hormone, luteinizing hormone, follicle-stimulating hormone, thyroid-stimulating hormone, estradiol, and vitamin D: a retrospective study in women with secondary infertility

Novelty in Biomedicine
Background: This study aims to evaluate the correlation between anti-Müllerian hormone, luteinizing hormone, follicle-stimulating hormone, thyroid-stimulating hormone, Estradiol, and vitamin D in women experiencing secondary infertility.
Zahra Moradi Ghadi, Elham Saffarieh, Maryam Ezzedin, Behpoor Yousefi, Azam Azargoon, Abbas Ziari, Najme Hemmatian, Nahid Azad   +7 more
doaj   +1 more source